Medlive Strengthens Advisory Board with Renowned Oncology Experts to Enhance Education
Medlive, a prominent provider of trusted education in the oncology sector, has made significant strides in enhancing its educational offerings by appointing three distinguished specialists to its Advisory Board. Renowned experts Ghassan Abou-Alfa, MD, JD, MBA, PhD(hc), Hans Lee, MD, and Aaron Lisberg, MD join forces with Medlive to further the company's mission of delivering evidence-based continuing medical education across various oncology disciplines, including hepatobiliary cancers, multiple myeloma, and thoracic oncology.
The appointment of these eminent oncologists signals Medlive's unwavering dedication to providing high-quality and clinically relevant education that tackles real-world challenges encountered by oncology practitioners, cancer patients, and their families. CEO, Robert Rosenbloom, emphasized, "These appointments reflect our ongoing commitment to delivering high-quality, clinically relevant education... Dr. Abou-Alfa, Dr. Lee, and Dr. Lisberg are respected leaders in their fields, and their insights will be invaluable as we continue to expand our educational portfolio."
Dr. Ghassan Abou-Alfa serves as a Professor of Medicine and attending physician at Memorial Sloan Kettering Cancer Center. He specializes in hepatobiliary malignancies, particularly hepatocellular carcinoma and cholangiocarcinoma, and his extensive clinical experience is set to elevate Medlive's educational initiatives in this crucial area.
Dr. Hans Lee is the Director of Myeloma Research at the Sarah Cannon Research Institute. His work focuses on developing innovative treatment strategies for multiple myeloma and related plasma cell disorders. Dr. Lee’s primary research is dedicated to advancing patient care through early phase clinical trials, and he has significantly contributed to leading peer-reviewed medical journals with his findings.
Dr. Aaron Lisberg is an Assistant Professor of Clinical Medicine at the David Geffen School of Medicine at UCLA, specializing in thoracic oncology. He has a keen interest in novel drug development, immunotherapy, and metabolic therapies for lung cancer. Dr. Lisberg’s collaboration with MedliveCME since 2020 has already enhanced educational offerings related to lung cancer therapies and access to clinical trials.
In a rapidly evolving healthcare landscape, Medlive plays a pivotal role in delivering impactful education tailored to the needs of healthcare providers, patients, and caregivers. By utilizing video-based learning modules, Medlive not only disseminates knowledge but also generates actionable insights and data that inform clinical practice. This strategic initiative is aimed at collaboratively advancing education that has tangible outcomes on patient health and wellbeing.
Additionally, Medlive’s extensive partner network has empowered millions of learners to stay abreast of the latest medical discoveries, driving improved health outcomes for all. As healthcare continues to evolve, Medlive’s proactive approach in expanding its educational framework will ensure that practitioners are equipped with the tools necessary for addressing the complexities of contemporary oncology.
Medlive's expansion of its Advisory Board underscores a pivotal moment in the organization's journey toward enhancing educational provisions in oncology. With the expertise of Dr. Abou-Alfa, Dr. Lee, and Dr. Lisberg, Medlive is well-positioned to continue spotlighting evidence-based practices and nurturing the next generation of healthcare professionals in the oncology field. For more information, visit the Medlive website or check their 'About Us' section to discover the breadth of their educational offerings.
Commitment to Excellence
The appointment of these eminent oncologists signals Medlive's unwavering dedication to providing high-quality and clinically relevant education that tackles real-world challenges encountered by oncology practitioners, cancer patients, and their families. CEO, Robert Rosenbloom, emphasized, "These appointments reflect our ongoing commitment to delivering high-quality, clinically relevant education... Dr. Abou-Alfa, Dr. Lee, and Dr. Lisberg are respected leaders in their fields, and their insights will be invaluable as we continue to expand our educational portfolio."
Profiles of New Advisory Board Members
Dr. Ghassan Abou-Alfa serves as a Professor of Medicine and attending physician at Memorial Sloan Kettering Cancer Center. He specializes in hepatobiliary malignancies, particularly hepatocellular carcinoma and cholangiocarcinoma, and his extensive clinical experience is set to elevate Medlive's educational initiatives in this crucial area.
Dr. Hans Lee is the Director of Myeloma Research at the Sarah Cannon Research Institute. His work focuses on developing innovative treatment strategies for multiple myeloma and related plasma cell disorders. Dr. Lee’s primary research is dedicated to advancing patient care through early phase clinical trials, and he has significantly contributed to leading peer-reviewed medical journals with his findings.
Dr. Aaron Lisberg is an Assistant Professor of Clinical Medicine at the David Geffen School of Medicine at UCLA, specializing in thoracic oncology. He has a keen interest in novel drug development, immunotherapy, and metabolic therapies for lung cancer. Dr. Lisberg’s collaboration with MedliveCME since 2020 has already enhanced educational offerings related to lung cancer therapies and access to clinical trials.
Advancing Education in Oncology
In a rapidly evolving healthcare landscape, Medlive plays a pivotal role in delivering impactful education tailored to the needs of healthcare providers, patients, and caregivers. By utilizing video-based learning modules, Medlive not only disseminates knowledge but also generates actionable insights and data that inform clinical practice. This strategic initiative is aimed at collaboratively advancing education that has tangible outcomes on patient health and wellbeing.
Additionally, Medlive’s extensive partner network has empowered millions of learners to stay abreast of the latest medical discoveries, driving improved health outcomes for all. As healthcare continues to evolve, Medlive’s proactive approach in expanding its educational framework will ensure that practitioners are equipped with the tools necessary for addressing the complexities of contemporary oncology.
Conclusion
Medlive's expansion of its Advisory Board underscores a pivotal moment in the organization's journey toward enhancing educational provisions in oncology. With the expertise of Dr. Abou-Alfa, Dr. Lee, and Dr. Lisberg, Medlive is well-positioned to continue spotlighting evidence-based practices and nurturing the next generation of healthcare professionals in the oncology field. For more information, visit the Medlive website or check their 'About Us' section to discover the breadth of their educational offerings.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.